A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Clinical Trial ID NCT01277146

PubWeight™ 11.67‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01277146

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015 2.02
2 Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther 2013 1.96
3 Notch inhibitors for cancer treatment. Pharmacol Ther 2013 1.55
4 Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012 1.17
5 Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov 2016 0.98
6 Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer. Clin Cancer Res 2014 0.95
7 Notching on Cancer's Door: Notch Signaling in Brain Tumors. Front Oncol 2015 0.95
8 Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev 2013 0.86
9 Notch signaling deregulation in multiple myeloma: A rational molecular target. Oncotarget 2015 0.81
10 Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther 2016 0.79
Next 100